about
Growth factors in idiopathic pulmonary fibrosis: relative rolesCell-specific gene expression in patients with usual interstitial pneumonia.Laser capture microdissection reveals dose-response of gene expression in situ consequent to asbestos exposure.Endogenous annexin A1 counter-regulates bleomycin-induced lung fibrosis.Small interfering RNAs (siRNAs) targeting TGF-beta1 mRNA suppress asbestos-induced expression of TGF-beta1 and CTGF in fibroblasts.Human pulmonary fibroblasts exhibit altered interleukin-4 and interleukin-13 receptor subunit expression in idiopathic interstitial pneumoniaThy-1 expression regulates the ability of rat lung fibroblasts to activate transforming growth factor-beta in response to fibrogenic stimuli.Augmented pulmonary IL-4 and IL-13 receptor subunit expression in idiopathic interstitial pneumoniaCaveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosisImpact of interleukin-13 responsiveness on the synthetic and proliferative properties of Th1- and Th2-type pulmonary granuloma fibroblastsRespiratory reovirus 1/L induction of intraluminal fibrosis, a model of bronchiolitis obliterans organizing pneumonia, is dependent on T lymphocytesCYLD negatively regulates transforming growth factor-β-signalling via deubiquitinating AktEngraftment of bone marrow progenitor cells in a rat model of asbestos-induced pulmonary fibrosisTransient expression of IL-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis.Expression of WNT5A in Idiopathic Pulmonary Fibrosis and Its Control by TGF-β and WNT7B in Human Lung Fibroblasts.Fibrosis in connective tissue disease: the role of the myofibroblast and fibroblast-epithelial cell interactionsDetecting splicing variants in idiopathic pulmonary fibrosis from non-differentially expressed genes.Update in occupational and environmental respiratory disease 2007.miR-877-3p targets Smad7 and is associated with myofibroblast differentiation and bleomycin-induced lung fibrosisHaploinsufficiency of the folliculin gene leads to impaired functions of lung fibroblasts in patients with Birt-Hogg-Dubé syndrome.Modulation of reactive oxygen species by Rac1 or catalase prevents asbestos-induced pulmonary fibrosisImatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis.Lung epithelial wound healing in health and disease.Myofibroblast differentiation and survival in fibrotic disease.Update on models of pulmonary fibrosis therapy for preclinical drug research.Pathogenesis, current treatments and future directions for idiopathic pulmonary fibrosis.Iron loading makes a nonfibrogenic model air pollutant particle fibrogenic in rat tracheal explants.Myofibroblast repair mechanisms post-inflammatory response: a fibrotic perspective.Prostaglandin E2-Dependent Phosphorylation of RAS Inhibition 1 (RIN1) at Ser 291 and 292 Inhibits Transforming Growth Factor-β-Induced RAS Activation Pathway in Human Synovial Fibroblasts: Role in Cell Migration.EM703, a new derivative of erythromycin, inhibits transforming growth factor-beta signaling in human lung fibroblasts.Transforming growth factor-beta1 induces heparan sulfate 6-O-endosulfatase 1 expression in vitro and in vivo.Differences in the fibrogenic response after transfer of active transforming growth factor-beta1 gene to lungs of "fibrosis-prone" and "fibrosis-resistant" mouse strains.Proteoglycans decorin and biglycan differentially modulate TGF-beta-mediated fibrotic responses in the lung.Mesenchymal cell survival in airway and interstitial pulmonary fibrosis.Role of caveolae in high glucose and TGF-β₁ induced fibronectin production in rat mesangial cells.PDE4 inhibitors roflumilast and rolipram augment PGE2 inhibition of TGF-{beta}1-stimulated fibroblasts.Comparing study of the effect of nanosized silicon dioxide and microsized silicon dioxide on fibrogenesis in rats.The latent form of TGFbeta(1) is induced by TNFalpha through an ERK specific pathway and is activated by asbestos-derived reactive oxygen species in vitro and in vivo.Impact of Olmesartan Medoxomil on Amiodarone-Induced Pulmonary Toxicity in Rats: Focus on Transforming Growth Factor-ß1.Adenoviral gene transfer of connective tissue growth factor in the lung induces transient fibrosis.
P2860
Q24798972-5B673190-E8F9-4EB2-B3C5-77C15A5A58DAQ33244817-1B9EFE85-2CBE-4A0F-91CF-1E9ABB93F01FQ33307198-BBC9D3EF-3F93-4ECB-B64C-19F867EF052CQ34051566-298DFAE2-1372-4869-BE02-110BE6FDC3D5Q34696587-C7B43716-100F-4CE5-B9CC-83AB1970401CQ35098429-F0727BA0-E633-4994-9B99-396C223F144BQ35103031-19CC38D3-0C70-4CBB-9A65-41D5DD2E5D62Q35587603-CD319134-CF5D-44C5-A0E7-2C31C275C9CAQ35748291-C8DE869A-FF02-421E-B7F8-B16AFCB0E3C5Q35749147-712863EB-10C4-4C9B-B771-FE7F1C0173D6Q35792214-0987D252-D6AF-49C0-858C-2AD5756A868AQ35916665-5E8A41D1-1E8D-4A08-9F72-6797FAA53A96Q36013643-6B3BC207-7296-4DE5-9C03-9EB4D36CC929Q36028616-BF1B54D2-4317-4996-A90B-A0AFB00691C5Q36742592-92228D5B-E2CB-4460-B5D0-B40DC9D70281Q36927753-8EFBAF71-B4B3-48D5-8F4E-D96523DEB029Q36976480-DBBB1F05-E9BE-478C-9946-6797134B02B9Q37117296-2CCD35B1-09FF-426F-BA43-65C703931F3AQ37117435-366311C1-CB18-4C1C-811F-2838DB762D5BQ37419031-B4473D96-5096-44C8-BE52-F2294B81AD13Q37421274-A7811B2E-AC39-400F-9131-8E34D35CD8B5Q37591872-C975E0EF-6207-472C-84F2-737BEC1AEC1AQ37798031-1F6243D2-3628-4DA5-A863-E1A37147967BQ37921386-F21E8F68-DE86-4754-9353-81CF7BE1943BQ38088363-B69A97E4-9C9B-4A1B-9608-8A9B6BC855B3Q38100470-73D1CBD4-48D9-4A07-A14F-2638AAEEEAB6Q38288826-ABFC4EAD-ABE0-464A-86C4-61D2AA8E322AQ39063947-75363CE5-F3BE-4EBE-98DF-215F8D41D379Q39801563-B7B31A73-6274-48D3-8B1F-47739BAE88FAQ39965277-D94CB2F5-7A11-4E9F-AC62-A45CD0871AD1Q39978694-01BF3D95-63A5-4EC7-A7BA-848813860B7BQ40714048-935AC3AF-DA76-4EDF-90A1-00C862142310Q40806556-EFA8326D-E24C-4016-A8B7-D037559B5151Q41855310-FE0ACD6B-1C9B-41BA-8408-A1205D81EC93Q43127146-52E77041-8D01-4B51-8F71-D6FBFDF79485Q46079226-001104E8-BAEA-457A-A50C-CDD2AAC554A6Q46419177-67F54CF3-3DB6-4683-B104-9020DB794A2CQ46527507-EC305080-1E6C-41FF-BF6F-1F47D997207AQ46608132-CC5E165A-0646-4B6E-93CA-FD88674E6501Q47817504-9C70FBB8-7AEC-4E59-9820-4CB176CC7459
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Interstitial fibrosis and growth factors
@ast
Interstitial fibrosis and growth factors
@en
Interstitial fibrosis and growth factors
@nl
type
label
Interstitial fibrosis and growth factors
@ast
Interstitial fibrosis and growth factors
@en
Interstitial fibrosis and growth factors
@nl
prefLabel
Interstitial fibrosis and growth factors
@ast
Interstitial fibrosis and growth factors
@en
Interstitial fibrosis and growth factors
@nl
P2860
P3181
P356
P1476
Interstitial fibrosis and growth factors
@en
P2093
P2860
P304
P3181
P356
10.1289/EHP.00108S4751
P407
P478
108 Suppl 4
P577
2000-08-01T00:00:00Z